Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-337124
Filing Date
2025-12-30
Accepted
2025-12-30 16:15:13
Documents
20
Period of Report
2025-12-30

Document Format Files

Seq Description Document Type Size
1 6-K d214993d6k.htm 6-K 12189
2 EX-1.1 d214993dex11.htm EX-1.1 1233422
3 GRAPHIC g214993dsp174.jpg GRAPHIC 2904
4 GRAPHIC g214993dsp175.jpg GRAPHIC 3241
5 GRAPHIC g214993dsp177.jpg GRAPHIC 3267
6 GRAPHIC g214993dsp178.jpg GRAPHIC 3330
7 GRAPHIC g214993dsp179.jpg GRAPHIC 2891
8 GRAPHIC g214993dsp180.jpg GRAPHIC 4713
9 GRAPHIC g214993dsp_24a.jpg GRAPHIC 4088
10 GRAPHIC g214993dsp_25a.jpg GRAPHIC 8516
11 GRAPHIC g214993dsp_25b.jpg GRAPHIC 3517
12 GRAPHIC g214993dsp_26a.jpg GRAPHIC 6627
13 GRAPHIC g214993dsp_33a.jpg GRAPHIC 4038
14 GRAPHIC g214993dsp_33b.jpg GRAPHIC 8461
15 GRAPHIC g214993dsp_34a.jpg GRAPHIC 3435
16 GRAPHIC g214993dsp_34b.jpg GRAPHIC 6195
17 GRAPHIC g214993page43.jpg GRAPHIC 4095
18 GRAPHIC g214993page44a.jpg GRAPHIC 8242
19 GRAPHIC g214993page44b.jpg GRAPHIC 3273
20 GRAPHIC g214993page45.jpg GRAPHIC 6491
  Complete submission text file 0001193125-25-337124.txt   1369632
Mailing Address TUBORG BOULEVARD 12 HELLERUP Denmark
Business Address TUBORG BOULEVARD 12 HELLERUP Denmark 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 251614442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)